Literature DB >> 27476775

Metastatic ocular melanoma to the liver exhibits infiltrative and nodular growth patterns.

Hans E Grossniklaus1, Qing Zhang2, Shuo You3, Conni McCarthy4, Steffen Heegaard5, Sarah E Coupland4.   

Abstract

We examined liver specimens from 15 patients with uveal melanoma (UM) who had died of their disseminated disease. We found 2 distinct growth patterns of UM metastasis: infiltrative (n = 12) and nodular (n = 3). In the infiltrative pattern, individual UM cells with a CD133+ cancer stem cell-like phenotype were present and formed aggregates of stage I <50-μm-diameter micrometastases in the sinusoidal spaces. These micrometastases appeared to expand, destroy adjacent hepatocytes, and form stage II 51- to 500-μm-diameter and then stage III >500μm-diameter metastases, which were encapsulated by collagenized fibrous septae. In the nodular growth pattern, CD133+ melanoma cells aggregated adjacent to portal venules and subsequently appeared to grow and efface the adjacent hepatocytes to form stage II 51- to 500-μm-diameter nodules that surrounded the portal venule. These avascular nodules appeared to further expand to form stage III >500-μm-diameter nodules that exhibited vascularization with minimal fibrosis. The tumor stem cell-like phenotype seen in individual UM cells was lost as the tumors progressed. There were CD56+ natural killer cells in sinusoidal spaces and CD3+ lymphocytes in periportal areas. The nodular growth pattern showed UM cells expressing MMP9 and VEGF. UM cells in both above-described growth patterns exhibited variable BAP1 expression. We propose that changes in the liver microenvironment are related to metastatic UM growth. We hypothesize that these changes include immune regulation within the sinusoidal space for the infiltrative pattern and changes in the VEGF/PEDF ratio for the nodular pattern.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Growth patterns; Liver metastases; Micrometastases; NK cells; Ocular melanoma; PEDF

Mesh:

Substances:

Year:  2016        PMID: 27476775      PMCID: PMC5547398          DOI: 10.1016/j.humpath.2016.07.012

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  37 in total

1.  Uveal melanoma: implications of tumor doubling time.

Authors:  A D Singh
Journal:  Ophthalmology       Date:  2001-05       Impact factor: 12.079

Review 2.  The Zimmerman-McLean-Foster hypothesis: 25 years later.

Authors:  A D Singh; I G Rennie; T Kivela; S Seregard; H Grossniklaus
Journal:  Br J Ophthalmol       Date:  2004-07       Impact factor: 4.638

3.  Insights into genetic alterations of liver metastases from uveal melanoma.

Authors:  Conni McCarthy; Helen Kalirai; Sarah L Lake; Andrew Dodson; Bertil E Damato; Sarah E Coupland
Journal:  Pigment Cell Melanoma Res       Date:  2016-01       Impact factor: 4.693

4.  Protein MRI contrast agent with unprecedented metal selectivity and sensitivity for liver cancer imaging.

Authors:  Shenghui Xue; Hua Yang; Jingjuan Qiao; Fan Pu; Jie Jiang; Kendra Hubbard; Khan Hekmatyar; Jason Langley; Mani Salarian; Robert C Long; Robert G Bryant; Xiaoping Philip Hu; Hans E Grossniklaus; Zhi-Ren Liu; Jenny J Yang
Journal:  Proc Natl Acad Sci U S A       Date:  2015-05-13       Impact factor: 11.205

5.  Frequent mutation of BAP1 in metastasizing uveal melanomas.

Authors:  J William Harbour; Michael D Onken; Elisha D O Roberson; Shenghui Duan; Li Cao; Lori A Worley; M Laurin Council; Katie A Matatall; Cynthia Helms; Anne M Bowcock
Journal:  Science       Date:  2010-11-04       Impact factor: 47.728

6.  Exome sequencing identifies recurrent somatic mutations in EIF1AX and SF3B1 in uveal melanoma with disomy 3.

Authors:  Marcel Martin; Lars Maßhöfer; Petra Temming; Sven Rahmann; Claudia Metz; Norbert Bornfeld; Johannes van de Nes; Ludger Klein-Hitpass; Alan G Hinnebusch; Bernhard Horsthemke; Dietmar R Lohmann; Michael Zeschnigk
Journal:  Nat Genet       Date:  2013-06-23       Impact factor: 38.330

7.  Host pigment epithelium-derived factor (PEDF) prevents progression of liver metastasis in a mouse model of uveal melanoma.

Authors:  John M Lattier; Hua Yang; Susan Crawford; Hans E Grossniklaus
Journal:  Clin Exp Metastasis       Date:  2013-06-22       Impact factor: 5.150

8.  Regulation of uveal melanoma interconverted phenotype by hepatocyte growth factor/scatter factor (HGF/SF).

Authors:  M J Hendrix; E A Seftor; R E Seftor; D A Kirschmann; L M Gardner; H C Boldt; M Meyer; J Pe'er; R Folberg
Journal:  Am J Pathol       Date:  1998-04       Impact factor: 4.307

9.  Expression of CD133 and other putative stem cell markers in uveal melanoma.

Authors:  Michelle Thill; Marc Jean Berna; Rebecca Grierson; Inna Reinhart; Tobias Voelkel; Christoph Piechaczek; Peter Galambos; Martine J Jager; Gisbert Richard; Claudia Lange; Ursula M Gehling
Journal:  Melanoma Res       Date:  2011-10       Impact factor: 3.599

10.  Depletion of NK cell activity results in growth of hepatic micrometastases in a murine ocular melanoma model.

Authors:  S A Dithmar; D A Rusciano; C A Armstrong; M J Lynn; H E Grossniklaus
Journal:  Curr Eye Res       Date:  1999-11       Impact factor: 2.424

View more
  22 in total

1.  Radiologic and Histopathologic Correlation of Different Growth Patterns of Metastatic Uveal Melanoma to the Liver.

Authors:  Albert Liao; Pardeep Mittal; David H Lawson; Jenny J Yang; Eszter Szalai; Hans E Grossniklaus
Journal:  Ophthalmology       Date:  2017-11-06       Impact factor: 12.079

2.  Uveal Melanoma Nuclear BRCA1-Associated Protein-1 Immunoreactivity Is an Indicator of Metastasis.

Authors:  Eszter Szalai; Jill R Wells; Laura Ward; Hans E Grossniklaus
Journal:  Ophthalmology       Date:  2017-08-18       Impact factor: 12.079

Review 3.  Histopathological growth patterns of liver metastasis: updated consensus guidelines for pattern scoring, perspectives and recent mechanistic insights.

Authors:  Emily Latacz; Diederik Höppener; Ali Bohlok; Vincent Donckier; Peter M Siegel; Raymond Barnhill; Marco Gerling; Cornelis Verhoef; Peter B Vermeulen; Sophia Leduc; Sébastien Tabariès; Carlos Fernández Moro; Claire Lugassy; Hanna Nyström; Béla Bozóky; Giuseppe Floris; Natalie Geyer; Pnina Brodt; Laura Llado; Laura Van Mileghem; Maxim De Schepper; Ali W Majeed; Anthoula Lazaris; Piet Dirix; Qianni Zhang; Stéphanie K Petrillo; Sophie Vankerckhove; Ines Joye; Yannick Meyer; Alexander Gregorieff; Nuria Ruiz Roig; Fernando Vidal-Vanaclocha; Larsimont Denis; Rui Caetano Oliveira; Peter Metrakos; Dirk J Grünhagen; Iris D Nagtegaal; David G Mollevi; William R Jarnagin; Michael I D'Angelica; Andrew R Reynolds; Michail Doukas; Christine Desmedt; Luc Dirix
Journal:  Br J Cancer       Date:  2022-06-01       Impact factor: 9.075

4.  Replacement and desmoplastic histopathological growth patterns: A pilot study of prediction of outcome in patients with uveal melanoma liver metastases.

Authors:  Raymond Barnhill; Peter Vermeulen; Sofie Daelemans; Pieter-Jan van Dam; Sergio Roman-Roman; Vincent Servois; Ilse Hurbain; Sophie Gardrat; Graça Raposa; André Nicolas; Rémi Dendale; Gaëlle Pierron; Laurence Desjardins; Nathalie Cassoux; Sophie Piperno-Neumann; Pascale Mariani; Claire Lugassy
Journal:  J Pathol Clin Res       Date:  2018-08-23

5.  Development and optimization of orthotopic liver metastasis xenograft mouse models in uveal melanoma.

Authors:  Takahito Sugase; Bao Q Lam; Meggie Danielson; Mizue Terai; Andrew E Aplin; J Silvio Gutkind; Takami Sato
Journal:  J Transl Med       Date:  2020-05-20       Impact factor: 5.531

6.  CD8 Positive T Lymphocyte Infiltration of Liver Metastases of Uveal Melanoma: A Case Report.

Authors:  Naoki Takahashi; Kazuto Tajiri; Ko Kagoyana; Shinichi Tanaka; Ichiro Yasuda
Journal:  Front Oncol       Date:  2021-06-02       Impact factor: 6.244

7.  Evaluation of VEGF and PEDF in prostate cancer: A preliminary study in serum and biopsies.

Authors:  Josué Rivera-Pérez; María Del Rocío Monter-Vera; Cornelio Barrientos-Alvarado; Julia D Toscano-Garibay; Teresa Cuesta-Mejías; Javier Flores-Estrada
Journal:  Oncol Lett       Date:  2017-11-08       Impact factor: 2.967

8.  Transcriptional inhibition by CDK7/9 inhibitor SNS-032 abrogates oncogene addiction and reduces liver metastasis in uveal melanoma.

Authors:  Jing Zhang; Shenglan Liu; Qianyun Ye; Jingxuan Pan
Journal:  Mol Cancer       Date:  2019-09-16       Impact factor: 27.401

Review 9.  Mouse models of uveal melanoma: Strengths, weaknesses, and future directions.

Authors:  Jackson R Richards; Jae Hyuk Yoo; Donghan Shin; Shannon J Odelberg
Journal:  Pigment Cell Melanoma Res       Date:  2020-01-22       Impact factor: 4.693

10.  Chemokine receptor 4 targeted protein MRI contrast agent for early detection of liver metastases.

Authors:  Shanshan Tan; Hua Yang; Shenghui Xue; Jingjuan Qiao; Mani Salarian; Khan Hekmatyar; Yuguang Meng; Rao Mukkavilli; Fan Pu; Oluwatosin Y Odubade; Wayne Harris; Yan Hai; Melinda L Yushak; Vanessa M Morales-Tirado; Pardeep Mittal; Phillip Z Sun; David Lawson; Hans E Grossniklaus; Jenny J Yang
Journal:  Sci Adv       Date:  2020-02-07       Impact factor: 14.136

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.